PMS2 p.Pro299Ser
c.895C>T · rs1562663421 · VCV1765250
Computational evidence
| Protein change | ||
| AlphaMissense | 0.2514 | likely benign |
|---|---|---|
| REVEL | 0.693 | pathogenic-leaning |
| SaProt | LLR -6.93 | tolerated |
| ⇒ REVEL calls this damaging; AlphaMissense and SaProt do not. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 12 | phastCons 1 |
| Regional constraint | o/e 1.09 | unconstrained · MANE · 22 kb · p 0.015 · regional, not allelic |
| Overall | ||
| CADD | 29.2 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.
Variant & gene context
- Gene
- PMS2
- Protein
- p.Pro299Ser
- Coding
- c.895C>T
- MANE Select
- NM_000535
- dbSNP
- rs1562663421
- Type
- single nucleotide variant
- Location
- chr7:5995542 (GRCh38)
- Gene constraint
- LOEUF 0.898 · pLI <0.01 · ClinGen HI 3/3 (gnomAD)
- Structure
- AlphaFold pLDDT 71.37 · 9 PDB
Similar variants
- PMS2 p.Pro299Leu Uncertain significance ★★ ⚠ same residue
- PMS2 p.Pro299Thr Uncertain significance ★★ ⚠ same residue
- PMS2 p.Pro299= Benign/Likely benign ★★ same residue
- PMS2 p.Pro299Arg Uncertain significance ★ ⚠ same residue
- PMS2 p.Pro299Gln Uncertain significance ★ same residue
- PMS2 c.163+2T>C Likely pathogenic ★★★ same condition
- PMS2 c.164-2A>G Likely pathogenic ★★★ same condition
- PMS2 c.2007-1G>A Likely pathogenic ★★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/pms2-p-pro299ser (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown